84 related articles for article (PubMed ID: 11181063)
1. Repression of CD2 gene expression is mediated by an AP-2 related factor.
Outram SV; Grimwade D; Crompton T
Biochem Biophys Res Commun; 2001 Feb; 281(2):409-15. PubMed ID: 11181063
[TBL] [Abstract][Full Text] [Related]
2. Induction of transcripts derived from promoter III of the acetyl-CoA carboxylase-alpha gene in mammary gland is associated with recruitment of SREBP-1 to a region of the proximal promoter defined by a DNase I hypersensitive site.
Barber MC; Vallance AJ; Kennedy HT; Travers MT
Biochem J; 2003 Oct; 375(Pt 2):489-501. PubMed ID: 12871210
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of transcription factor AP-2 stimulates the PA promoter of the human uracil-DNA glycosylase (UNG) gene through a mechanism involving derepression.
Aas PA; Peña-Diaz J; Liabakk NB; Krokan HE; Skorpen F
DNA Repair (Amst); 2009 Jul; 8(7):822-33. PubMed ID: 19411194
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
6. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
7. Delineation of the insulin-responsive sequence in the rat cytosolic aspartate aminotransferase gene: binding sites for hepatocyte nuclear factor-3 and nuclear factor I.
Beurton F; Bandyopadhyay U; Dieumegard B; Barouki R; Aggerbeck M
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):687-95. PubMed ID: 10527950
[TBL] [Abstract][Full Text] [Related]
8. NF1 regulatory element functions as a repressor of tissue plasminogen activator expression.
Pham NL; Franzen A; Levin EG
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):982-7. PubMed ID: 15044208
[TBL] [Abstract][Full Text] [Related]
9. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the promoter of 1A6/DRIM, a novel cancer-related gene and identification of its transcriptional activator.
Xing X; Du X; Lu Z; Ning T; Su X; Ke Y
Gene; 2005 Jan; 344():161-9. PubMed ID: 15656982
[TBL] [Abstract][Full Text] [Related]
11. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
[TBL] [Abstract][Full Text] [Related]
12. Identification and analysis of the human neural polypyrimidine tract binding protein (nPTB) gene promoter region.
Romanelli MG; Lorenzi P; Morandi C
Gene; 2005 Aug; 356():11-8. PubMed ID: 16002244
[TBL] [Abstract][Full Text] [Related]
13. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
Xia T; Zeng G; Gao L; Yu RK
Gene; 2005 May; 351():109-18. PubMed ID: 15890474
[TBL] [Abstract][Full Text] [Related]
14. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
15. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
16. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
17. Functional mapping of the bovine Doppel gene promoter region.
Del Vecchio I; Azzalin A; Guidi E; Amati G; Caramori T; Uboldi C; Comincini S; Ferretti L
Gene; 2005 Aug; 356():101-8. PubMed ID: 15964157
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of the androgen receptor gene promoter by NFI and an adjacently located multiprotein-binding site.
Song CS; Jung MH; Supakar PC; Chatterjee B; Roy AK
Mol Endocrinol; 1999 Sep; 13(9):1487-96. PubMed ID: 10478840
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel SP3 binding site in the promoter of human IGFBP4 gene: role of SP3 and AP-1 in regulating promoter activity in CaCo2 cells.
Shen Q; Singh P
Oncogene; 2004 Apr; 23(14):2454-64. PubMed ID: 14767471
[TBL] [Abstract][Full Text] [Related]
20. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
